维普中文期刊产品整合服务
31篇 您的检索式:作者名="Costac"
    题名 作者 年代 出处 被引量
1Statin use and cognitive function in middle-aged adults with type 1 diabetes显示文摘AIM To test associations between statin use and cognitive impairment in adults with childhood-onset type 1 diabetes(T1D).METHODS In 2010-13, n = 108 middle-aged participants from ongoing observational Pittsburgh Epidemiology of Diabetes Complications Study underwent neurocognitive assessment(mean age and T1 D duration of 49 and 41 years, respectively). All were diagnosed with childhoodonset(i.e., prior to age 18) T1 D between 1950 and 1980 and were seen within one year of diagnosis at Children's Hospital of Pittsburgh. Self-reported statin use(yes/no and if yes, name of statin) was collected biennially from parent study baseline(1986-1988) to time of neurocognitive testing. Logistic regression models tested associations between statin use groups and cognitive impairment(defined as having two or more cognitive test scores 1.5SD or worse than published norms) while linear regression models tested associations between statin use groups and cognitive domain z-scores(domains: Verbal IQ, memory, executive function, psychomotor speed, and visuo-construction). All models controlled for education and age. To address confounding by indication, models were repeated using a propensity score for statin use.RESULTS Of the 108 participants, 51 reported never using statins. Median duration of statin use among the 57 ever users was 6 years. These 57 ever statin users were split to create two groups(≤ or > median years of statin use): 1-6 years(n = 25), and 7-12 years(n = 32). Compared with never users, using statins 1-6 years tripled the odds of cognitive impairment(OR = 3.16; 95%CI: 0.93-10.72; P = 0.06) and using statins 7-12 years almost quintupled the odds of cognitive impairment(OR = 4.84; 95%CI: 1.63-14.44; P = 0.005). Compared with never users, using statins 1-6 or 7-12 years was related to worse performance in the memory domain(β =-0.52; P = 0.003, and-0.39; P = 0.014, respectively). Adjusting for coronary artery disease, low density lipoprotein cholesterol, and Apo E4 status did not substantially alter results, and none of these covariates were significantly related to cognitive outcomes(all P > 0.05). Propensity score analyses support that associations between poor cognitive outcomes and statin use were not due merely to confounding by indication. CONCLUSION Statin use was associated with cognitive impairment, particularly affecting memory, in these middle-aged adults with childhood-onset T1 D, whom at this age, should not yet manifest age-related memory deficits.Karen A Nunley Trevor J Orchard Christopher M Ryan Rachel Miller Tina Costacou Caterina Rosano 2017World Journal of Diabetes2017,8,6:2
2Lower-extremity arterial calcification as a correlate of coronary artery calcification显示文摘Costacou T Huskey ND Edmundowicz D 2006Metabolism2006,55,12:1
3Plasma and dietary vita-min E in relation to incidence of type 2 diabetes:The Insulin Re-sistance and Atherosclerosis Study(IRAS)显示文摘Mayer-Davis EJ Costacou T King I 2002Diabetes Care2002,25,12:1
4The 30-year natural history of type 1 diabetes complications:the Pittsburgh Epidemi- ology of Diabetes Complications Study experience显示文摘Pambianco G Costacou T Ellis D 2006Diabetes2006,55,5:1
5Plasma and dietary vitamin E in relation to incidence of type 2 diabetes: the insulin resistance and atherosclerosis study (IRAS) 显示文摘MAYER - DAVIS E J COSTACOU T KING I 2002Diabetes Care2002,25,:1
6A very simple empirical kinetic model of the acidcatalyzed cure of urea-formaldehyde resins 显示文摘CARVALHO L M H COSTA M R PF N COSTAC A V 2006Journal of Applied Polymer Science2006,102,6:1
7Association of socioe- conomic status with mortality in type 1 diabetes: the Pittsburgh epidemiology of diabetes complications study 显示文摘Secrest AM Costacou T Gutelius B 2011Ann Epidemi- ol2011,21,5:1
8Clinical factors associated with resistance io microvascular complications in diabetic patients of extreme disease duration: the 50- year medalist study 显示文摘Keenan HA Costacou T Sun JK 2007Diabetes Care2007,30,8:1
9Plasma and dietary vitamin E in relation to incidence of type 2 diabetes: The Insulin Resistance and Atherosclerosis Study (IRAS) 显示文摘MAYER-DAVIS E J COSTACOU T KING I 2002Diabetes Care2002,25,:1
10Adiposity and mortality in type 1 diabetes 显示文摘Conway B Miller RG Costacou T 2009Int J Obes (Lond)2009,33,7:1
11The 30-year natural history of type 1 diabetes complications:the Pittsburgh Epidemiology of Diabetes Complications Study experience显示文摘PAMBIANCO G COSTACOU T ELLIS D 2006Diabetes2006,55,5:1
12Postpartum adiponeetin concentration, insulin resistance and metabolic abnormalities among women with pregnancy-induced disturbances 显示文摘Costacou T Bosnyak Z Harger GF 2008Prey Cardiol2008,11,2:1
13Analysisof raw meatto predict proteolysis in Parma ham显示文摘Schivazappaa C Degnib M Nanni Costac L 2002Meat Science2002,60,:1
14Haptoglobin geno- type: a determinant of cardiovascular complication risk in type I diabetes显示文摘Costacou T Ferrell RE Orchard TJ 2008Diabetes2008,57,:1
15Lower-extremity arterial calcification as a correlate of coronary artery calcification显示文摘Costacou T Huskey ND Edmundowicz D 2006Metabolism2006,55,14:1
16Adiposity and mortality in type 1 diabetes 显示文摘Conway B Miller RG Costacou T 2009International Journal of Obesity2009,33,7:1
17Nutrition and prevention of Type 2 diabetes显示文摘Costacou T Mayer-Davis E J 2003Ann Rev Nutr2003,23,:1
18Clinical factors associated with resistance to microvascular complications in diabetic patients of extreme disease duration显示文摘Keenan HA Costacou T Sun JK Doria A Cavellerano J Coney J 2007Diabetes Care2007,30,8:1
19Sleep and cognitive(memory) function:research and clinical perspectives显示文摘Roth T Costac e Slilva JA Chase MH 0,,05:1
20Adherence to a Mediterranean diet and survival in a Greek population 显示文摘Trichopoulou A Costacou T Bamia C 2003New Engl J Med2003,348,26:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费